Elanco Animal Health Inc

NYSE:ELAN  
23.86
+0.14 (+0.59%)
Other Pre-Announcement

Elanco Animal Health Reports Q1 Adj EPS $0.36

Published: 05/09/2022 13:45 GMT
Elanco Animal Health Inc (ELAN) - Elanco Animal Health Reports First Quarter 2022 Results.
Q1 Revenue Fell 1 Percent to $1.225 Billion.
Sees FY Earnings per Share $0.02 to $0.09.
Q1 Adjusted Earnings per Share $0.36.
Q1 Earnings per Share $0.10.
Sees Q2 Revenue $1.16 Billion to $1.2 Billion.
Sees FY Revenue $4.7 Billion to $4.755 Billion.
Announced Strategic Alliance With Royal Dsm, for Exclusive U.S. Rights to Bovaer®, a Methane-reducing Feed Product for Cattle.
Q1 Earnings per Share View $0.35, Revenue View $1.22 Billion -- Refinitiv Ibes Data (analyst estimates).
Q2 Earnings per Share View $0.34, Revenue View $1.27 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $1.21, Revenue View $4.77 Billion -- Refinitiv Ibes Data (analyst estimates).
Qtrly Pet Health Revenue Was $639 Million, a Decrease of 1% on a Reported Basis.
Qtrly Farm Animal Revenue Was $569 Million, a Decrease of 2% on a Reported Basis.
Sees Q2 Reported EPS Loss per Share $0.05 to Earnings per Share $0.02.
Implied Guidance for Second Half of 2022 Includes an Acceleration of Revenue and Profitability Growth.
Sees Q2 Adjusted EPS $0.22 to $0.28.
Updated Guidance for 2022 Now Includes Expected Benefit From Incremental Price Improvement and Sales Phasing in China.
Sees FY Adjusted EPS $1.15 to $1.21.